U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H43NO
Molecular Weight 361.6043
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of CLINOLAMIDE

SMILES

CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC1CCCCC1

InChI

InChIKey=OFSPDNIHQQKLPZ-HZJYTTRNSA-N
InChI=1S/C24H43NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-24(26)25-23-20-17-16-18-21-23/h6-7,9-10,23H,2-5,8,11-22H2,1H3,(H,25,26)/b7-6-,10-9-

HIDE SMILES / InChI

Description

Clinolamide (cyclohexylamine of linoleic acid) is a drug developed by a Japanese company Sumitomo Chemical Co. Ltd. Clinolamide has been found to lower serum and liver cholesterol levels and to reduce the severity of atherosclerosis in cholesterol-fed rabbits.

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
N-cyclohexyl linoleamide: metabolism and cholesterol-lowering effect in rats.
1966 Sep 9
Effect of N-cyclohexyl linoleamide on cholesterol metabolism in rats.
1968 Jan
Name Type Language
CLINOLAMIDE
INN  
INN  
Official Name English
LINOLEIC ACID CYCLOHEXYLAMIDE [MI]
Common Name English
LINOLEIC ACID CYCLOHEXYLAMIDE
MI  
Systematic Name English
clinolamide [INN]
Common Name English
N-CYCLOHEXYLLINOLEAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29703
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
Code System Code Type Description
INN
2187
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
FDA UNII
G90E14A6I6
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
PUBCHEM
6436114
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
EPA CompTox
DTXSID601043396
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
MERCK INDEX
m6830
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY Merck Index
CHEBI
60054
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
NCI_THESAURUS
C78053
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104127
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
EVMPD
SUB06667MIG
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
CAS
3207-50-9
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
SMS_ID
100000084277
Created by admin on Fri Dec 15 16:12:39 GMT 2023 , Edited by admin on Fri Dec 15 16:12:39 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of CLINOLAMIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966